Ansa Biotechnologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ansa Biotechnologies's estimated annual revenue is currently $16.1M per year.(i)
  • Ansa Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Ansa Biotechnologies has 104 Employees.(i)
  • Ansa Biotechnologies grew their employee count by 70% last year.

Ansa Biotechnologies's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP Research & DevelopmentReveal Email/Phone
3
General Counsel / Head IPReveal Email/Phone
4
Head DepartmentReveal Email/Phone
5
Head Systems IntegrationReveal Email/Phone
6
Head HardwareReveal Email/Phone
7
Head InnovationReveal Email/Phone
8
Head BiochemistryReveal Email/Phone
9
Head ChemistryReveal Email/Phone
10
Head DNA Assembly and co-founderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Ansa Biotechnologies?

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

keywords:N/A

N/A

Total Funding

104

Number of Employees

$16.1M

Revenue (est)

70%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ansa Biotechnologies News

2022-04-06 - Ansa Biotechnologies ties up $68M for DNA synthesis platform

San Francisco-area startup Ansa Biotechnologies is developing a new technology platform that aims to provide synthetic DNA for those uses and more—and one...

2022-04-06 - Ansa Biotechnologies Closes $68M Series A Financing

Ansa Biotechnologies, an Emeryville, CA-based developer of an enzymatic DNA synthesis technology, raised $68m in Series A financing.

2022-04-06 - Ansa Biotechnologies Closes Oversubscribed $68 Million ...

Ansa Biotechnologies is building a fast and reliable DNA synthesis service to accelerate synthetic biology research. Our core technology is a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M1057%N/A
#2
$35M1062%N/A
#3
$31M1079%N/A
#4
$29.2M10810%N/A
#5
$31.6M109-18%N/A